Search - tctmd.com

Displaying 401 - 420 of 461

Sort: Relevancy | Date

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

CVD Risk for Women Rises After Gestational Diabetes

Yael L. Maxwell

October 16, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

L.A. McKeown

August 24, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

News Daily News

Hormone Therapies May Have Adverse CV Effects in Transgender Adults

Ashley Lyles

July 24, 2017

News Daily News

ECGs Ordered After One in Five Annual Health Exams

Shelley Wood

July 13, 2017

News Daily News

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Michael O'Riordan

July 11, 2017

News Daily News

Breast Health, Weight Beat Out Cardiovascular Disease Concerns Among Doctors Treating Women

Ashley Lyles

June 28, 2017

News Daily News

Educational Attainment Inversely Associated With Lifetime Risk of CVD

Ashley Lyles

June 15, 2017

News Daily News

Cardiovascular Disease Is a Major Worldwide Threat to Public Health, Global Analysis Finds

Alison Palkhivala

May 25, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Daily News

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

Yael L. Maxwell

May 15, 2017

News Conference News EAS 2017

FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data

Yael L. Maxwell

April 26, 2017

Advertisement

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

CVD Risk for Women Rises After Gestational Diabetes

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Ischemic Heart Disease the Leading Cause of Death Globally

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Hormone Therapies May Have Adverse CV Effects in Transgender Adults

ECGs Ordered After One in Five Annual Health Exams

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Breast Health, Weight Beat Out Cardiovascular Disease Concerns Among Doctors Treating Women

Educational Attainment Inversely Associated With Lifetime Risk of CVD

Cardiovascular Disease Is a Major Worldwide Threat to Public Health, Global Analysis Finds

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content